Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07103278
PHASE1
A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-116 and the administration of AD-1161 in healthy adult male volunteers
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers Under Fasting Conditions
Key Details
Gender
MALE
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2025-12
Completion Date
2026-01
Last Updated
2025-10-03
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-116
AD-116 Oral Tablet
DRUG
AD-1161
AD-1161 Oral Capsule